46 results on '"De Stefano, Piero"'
Search Results
2. Antibody response to pneumococcal vaccine in children receiving bone marrow transplantation
3. Unrelated Bone Marrow Transplantation for β-Thalassemia Patients: The Experience of the Italian Bone Marrow Transplant Group
4. New insights into haematopoietic stem cell transplantation for patients with haemoglobinopathies
5. MODIFIED CHOP-CHEMOTHERAPY PLUS RITUXIMAB FOR DIFFUSE LARGE B-CELL LYMPHOMA COMPLICATING ATAXIA-TELANGIECTASIA
6. SUCCESSFUL UMBILICAL CORD BLOOD TRANSPLANTATION IN A CHILD WITH DYSKERATOSIS CONGENITA AFTER A FLUDARABINE-BASED REDUCED-INTENSITY CONDITIONING REGIMEN
7. Anti-CD20 monoclonal antibody (Rituximab) for life-threatening autoimmune haemolytic anaemia in a patient with systemic lupus erythematosus
8. Human cytomegalovirus immediate-early mRNAemia versus pp65 antigenemia for guiding pre-emptive therapy in children and young adults undergoing hematopoietic stem cell transplantation: a prospective, randomized, open-label trial
9. Rituximab for the treatment of refractory autoimmune hemolytic anemia in children
10. Resolution of immune haemolytic anaemia with allogeneic bone marrow transplantation after an unsuccessful autograft
11. The haemochromatosis mutations do not modify the clinical picture of thalassaemia major in patients regularly transfused and chelated
12. Survival and Disease Complications in Thalassemia Major
13. Unrelated donor bone marrow transplantation for thalassemia: the effect of extended haplotypes
14. T-cell depletion to prevent GVHD after unrelated-donor marrow transplantation
15. A trial of high-dose dexamethasone therapy for chronic idiopathic thrombocytopenic purpura in childhood
16. Role of allogeneic bone marrow transplantation from an HLA-identical sibling or a matched unrelated donor in the treatment of children with juvenile chronic myeloid leukaemia
17. Relationship between transfusion regimen and suppression of erythropoiesis in beta-thalassaemia major
18. Deferoxamine in Thalassemia Major
19. Intensive Iron-Chelation In Thalassaemia
20. Survival and causes of death in thalassanemia major
21. Graft rejection after unrelated donor hematopoietic stem cell transplantation for thalassemia is associated with nonpermissive HLA-DPB1 disparity in host-versus-graft direction
22. Unrelated bone marrow transplantation for beta-thalassemia patients: The experience of the Italian Bone Marrow Transplant Group
23. B lymphocyte reconstitution after hematopoietic stem cell transplantation: functional immaturity and slow recovery of memory CD27+ B cells
24. Familial platelet disorder with propensity to acute myelogenous leukemia: genetic heterogeneity and progression to leukemia via acquisition of clonal chromosome anomalies
25. Reconstitution dynamics of plasmacytoid and myeloid dendritic cell precursors after allogeneic myeloablative hematopoietic stem cell transplantation
26. Non-myeloablative stem cell transplantation for severe combined immunodeficiency--Omenn syndrome
27. B lymphocyte reconstitution after hematopoietic stem cell transplantation: functional immaturity and slow recovery of memory CD27+ B cells
28. T Cell-Mediated Control of HCMV Infection in Pediatric Patients Receiving Hematopoietic Stem Cell Transplantation.
29. Reconstitution dynamics of plasmacytoid and myeloid dendritic cell precursors after allogeneic myeloablative hematopoietic stem cell transplantation
30. Familial platelet disorder with propensity to acute myelogenous leukemia: Genetic heterogeneity and progression to leukemia via acquisition of clonal chromosome anomalies
31. Anti-CD20 monoclonal antibody for the treatment of severe, immune-mediated, pure red cell aplasia and hemolytic anemia
32. review New insights into haematopoietic stem cell transplantation for patients with haemoglobinopathies.
33. Cardiac morbidity and mortality in deferoxamine- or deferiprone-treated patients with thalassemia major
34. Hepatocellular carcinoma in thalassemia major
35. MARROW TRANSPLANTATION FOR THALASSAEMIA
36. VISUAL LOSS IN PATIENT ON HIGH-DOSE SUBCUTANEOUS DESFERRIOXAMINE
37. Radiological Case of the Month
38. correspondence Non-myeloablative stem cell transplantation for severe combined immunodeficiency – Omenn syndrome.
39. Radiological Case of the Month
40. B lymphocyte reconstitution after hematopoietic stem cell transplantation: functional immaturity and slow recovery of memory CD27+ B cells
41. Deferoxamine in Thalassemia Major.
42. Cholelithiasis in children with thalassemia major: An ultrasonographic study
43. Graft rejection after unrelated donor hematopoietic stem cell transplantation for thalassemia is associated with nonpermissive HLA-DPB1 disparity in host-versus-graft direction.
44. Unrelated bone marrow transplantation for beta-thalassemia patients: The experience of the Italian Bone Marrow Transplant Group.
45. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine.
46. Non-myeloablative stem cell transplantation for severe combined immunodeficiency--Omenn syndrome.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.